Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.

Protection from the toxicity of nerve agents is achieved by pretreatment with human butyrylcholinesterase (BChE). Current methods for purifying large quantities of BChE from frozen Cohn fraction IV-4 produce 99% pure enzyme, but the yield is low (21%). Our goal was to simplify the purification proce...

Full description

Bibliographic Details
Main Authors: Lawrence M Schopfer, Emilie David, Steven H Hinrichs, Oksana Lockridge
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0280380
_version_ 1797943983834398720
author Lawrence M Schopfer
Emilie David
Steven H Hinrichs
Oksana Lockridge
author_facet Lawrence M Schopfer
Emilie David
Steven H Hinrichs
Oksana Lockridge
author_sort Lawrence M Schopfer
collection DOAJ
description Protection from the toxicity of nerve agents is achieved by pretreatment with human butyrylcholinesterase (BChE). Current methods for purifying large quantities of BChE from frozen Cohn fraction IV-4 produce 99% pure enzyme, but the yield is low (21%). Our goal was to simplify the purification procedure and increase the yield. Butyrylcholinesterase was extracted from frozen Cohn fraction IV-4 in 10 volumes of water pH 6. The filtered extract was pumped onto a Hupresin affinity column. The previously utilized anion exchange chromatography step was omitted. Solvent and detergent reagents used to inactivate lipid enveloped virus, bacteria and protozoa did not bind to Hupresin. BChE was eluted with 0.1 M tetramethylammonium bromide in 20 mM sodium phosphate pH 8.0. BChE protein was concentrated on a Pellicon tangential flow filtration system and demonstrated to be highly purified by mass spectrometry. A high pump rate produced protein aggregates, but a low pump rate caused minimal turbidity. Possible contamination by prekallikrein and prekallikrein activator was examined by LC-MS/MS and by a chromogenic substrate assay for kallikrein activity. Prekallikrein and kallikrein were not detected by mass spectrometry in the 99% pure BChE. The chromogenic assay indicated kallikrein activity was less than 9 mU/mL. This new, 1-step chromatography protocol on Hupresin increased the yield of butyrylcholinesterase by 200%. The new method significantly reduces production costs by optimizing yield of 99% pure butyrylcholinesterase.
first_indexed 2024-04-10T20:31:29Z
format Article
id doaj.art-276bc035f5dc4e2db13f98512aa3fbd3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T20:31:29Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-276bc035f5dc4e2db13f98512aa3fbd32023-01-25T05:33:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01181e028038010.1371/journal.pone.0280380Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.Lawrence M SchopferEmilie DavidSteven H HinrichsOksana LockridgeProtection from the toxicity of nerve agents is achieved by pretreatment with human butyrylcholinesterase (BChE). Current methods for purifying large quantities of BChE from frozen Cohn fraction IV-4 produce 99% pure enzyme, but the yield is low (21%). Our goal was to simplify the purification procedure and increase the yield. Butyrylcholinesterase was extracted from frozen Cohn fraction IV-4 in 10 volumes of water pH 6. The filtered extract was pumped onto a Hupresin affinity column. The previously utilized anion exchange chromatography step was omitted. Solvent and detergent reagents used to inactivate lipid enveloped virus, bacteria and protozoa did not bind to Hupresin. BChE was eluted with 0.1 M tetramethylammonium bromide in 20 mM sodium phosphate pH 8.0. BChE protein was concentrated on a Pellicon tangential flow filtration system and demonstrated to be highly purified by mass spectrometry. A high pump rate produced protein aggregates, but a low pump rate caused minimal turbidity. Possible contamination by prekallikrein and prekallikrein activator was examined by LC-MS/MS and by a chromogenic substrate assay for kallikrein activity. Prekallikrein and kallikrein were not detected by mass spectrometry in the 99% pure BChE. The chromogenic assay indicated kallikrein activity was less than 9 mU/mL. This new, 1-step chromatography protocol on Hupresin increased the yield of butyrylcholinesterase by 200%. The new method significantly reduces production costs by optimizing yield of 99% pure butyrylcholinesterase.https://doi.org/10.1371/journal.pone.0280380
spellingShingle Lawrence M Schopfer
Emilie David
Steven H Hinrichs
Oksana Lockridge
Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.
PLoS ONE
title Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.
title_full Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.
title_fullStr Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.
title_full_unstemmed Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.
title_short Human butyrylcholinesterase in Cohn fraction IV-4 purified in a single chromatography step on Hupresin.
title_sort human butyrylcholinesterase in cohn fraction iv 4 purified in a single chromatography step on hupresin
url https://doi.org/10.1371/journal.pone.0280380
work_keys_str_mv AT lawrencemschopfer humanbutyrylcholinesteraseincohnfractioniv4purifiedinasinglechromatographysteponhupresin
AT emiliedavid humanbutyrylcholinesteraseincohnfractioniv4purifiedinasinglechromatographysteponhupresin
AT stevenhhinrichs humanbutyrylcholinesteraseincohnfractioniv4purifiedinasinglechromatographysteponhupresin
AT oksanalockridge humanbutyrylcholinesteraseincohnfractioniv4purifiedinasinglechromatographysteponhupresin